0 0 Little 3 Healthcare Ltd 14197835 false 2024-07-01 2025-06-30 2025-06-30 The principal activity of the company is Private Health Care Digita Accounts Production Advanced 6.30.9574.0 true 14197835 2024-07-01 2025-06-30 14197835 2025-06-30 14197835 bus:Director1 1 2025-06-30 14197835 bus:Director2 1 2025-06-30 14197835 bus:OrdinaryShareClass1 2025-06-30 14197835 core:CurrentFinancialInstruments 2025-06-30 14197835 core:CurrentFinancialInstruments core:WithinOneYear 2025-06-30 14197835 core:FurnitureFittingsToolsEquipment 2025-06-30 14197835 bus:SmallEntities 2024-07-01 2025-06-30 14197835 bus:AuditExemptWithAccountantsReport 2024-07-01 2025-06-30 14197835 bus:FilletedAccounts 2024-07-01 2025-06-30 14197835 bus:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 14197835 bus:RegisteredOffice 2024-07-01 2025-06-30 14197835 bus:Director1 2024-07-01 2025-06-30 14197835 bus:Director1 1 2024-07-01 2025-06-30 14197835 bus:Director2 2024-07-01 2025-06-30 14197835 bus:Director2 1 2024-07-01 2025-06-30 14197835 bus:OrdinaryShareClass1 2024-07-01 2025-06-30 14197835 bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 14197835 bus:Agent1 2024-07-01 2025-06-30 14197835 core:FurnitureFittingsToolsEquipment 2024-07-01 2025-06-30 14197835 countries:Wales 2024-07-01 2025-06-30 14197835 2024-06-30 14197835 bus:Director1 1 2024-06-30 14197835 bus:Director2 1 2024-06-30 14197835 core:FurnitureFittingsToolsEquipment 2024-06-30 14197835 2023-07-01 2024-06-30 14197835 2024-06-30 14197835 bus:Director1 1 2024-06-30 14197835 bus:Director2 1 2024-06-30 14197835 bus:OrdinaryShareClass1 2024-06-30 14197835 core:CurrentFinancialInstruments 2024-06-30 14197835 core:CurrentFinancialInstruments core:WithinOneYear 2024-06-30 14197835 core:FurnitureFittingsToolsEquipment 2024-06-30 14197835 bus:Director1 2023-07-01 2024-06-30 14197835 bus:Director1 1 2023-07-01 2024-06-30 14197835 bus:Director2 2023-07-01 2024-06-30 14197835 bus:Director2 1 2023-07-01 2024-06-30 14197835 bus:OrdinaryShareClass1 2023-07-01 2024-06-30 14197835 bus:Director1 1 2023-06-30 14197835 bus:Director2 1 2023-06-30 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 14197835

Little 3 Healthcare Ltd
Unaudited Filleted Financial Statements
for the Year Ended 30 June 2025

Little 3 Healthcare Ltd

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 8

Little 3 Healthcare Ltd

Company Information

Directors | Tomas Brendan O Neill Dr Neonin Mc Ardle

Registered office | 4th Floor 14 Museum Place City Centre Cardiff Wales CF10 3BH

Accountants | SP McKeown & Co Ltd Chartered Certified Accountants, Registered Auditors and Tax Advisors5 Lower Catherine Street Newry Co Down BT35 6BE

Little 3 Healthcare Ltd

(Registration number: 14197835)
Balance Sheet as at 30 June 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 3,285 | 3,437
Current assets |  |  |
Debtors | 5 | 2 | 2
Cash at bank and in hand |  | 32,791 | 43,322
|  | 32,793 | 43,324
Creditors: Amounts falling due within one year | 6 | (5,589) | (5,777)
Net current assets |  | 27,204 | 37,547
Total assets less current liabilities |  | 30,489 | 40,984
Provisions for liabilities |  | (624) | (653)
Net assets |  | 29,865 | 40,331
Capital and reserves |  |  |
Called up share capital | 7 | 2 | 2
Retained earnings |  | 29,863 | 40,329
Shareholders' funds |  | 29,865 | 40,331

For the financial year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 9 January 2026 and signed on its behalf by:

......................................... Tomas Brendan O Neill Director | ......................................... Dr Neonin Mc Ardle Director |

Little 3 Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

1 | General information

The company is a private company limited by share capital, incorporated in Wales.

The address of its registered office is:
4th Floor
14 Museum Place
City Centre
Cardiff
CF10 3BH
Wales

These financial statements were authorised for issue by the Board on 9 January 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Little 3 Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.
Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Little 3 Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2024 - 0).

Little 3 Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

4 | Tangible assets

| Furniture, fittings and equipment £ | Total £
Cost or valuation
At 1 July 2024 | 4,175 | 4,175
Additions | 560 | 560
At 30 June 2025 | 4,735 | 4,735
Depreciation
At 1 July 2024 | 738 | 738
Charge for the year | 712 | 712
At 30 June 2025 | 1,450 | 1,450
Carrying amount
At 30 June 2025 | 3,285 | 3,285
At 30 June 2024 | 3,437 | 3,437

5 | Debtors

Current | 2025 £ | 2024 £
Other debtors | 2 | 2
| 2 | 2

6 | Creditors

Creditors: amounts falling due within one year

| 2025 £ | 2024 £
Due within one year |  |
Taxation and social security | - | 1,499
Accruals and deferred income | 700 | 600
Other creditors | 4,889 | 3,678
| 5,589 | 5,777

7 | Share capital

Allotted, called up and fully paid shares

Little 3 Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

| 2025 | 2024
| No. | £ | No. | £
Ordinary shares of £1 each | 2 | 2 | 2 | 2

8 | Dividends

Interim dividends paid

|  | 2025 £ |  | 2024 £
Interim dividend of £1,000.00 per each Ordinary shares |  | 2,000 |  | 2,000

9 | Related party transactions

Transactions with directors

2025 | At 1 July 2024 £ | Advances to director £ | Repayments by director £ | At 30 June 2025 £
Tomas Brendan O Neill
Directors loan | 840 | 335 | 1,450 | 2,625
Dr Neonin Mc Ardle
Directors loan | 2,838 | 1,354 | 1,450 | 5,642

2024 | At 1 July 2023 £ | Advances to director £ | Repayments by director £ | At 30 June 2024 £
Tomas Brendan O Neill
Directors loan | 3,467 | (4,077) | 1,450 | 840
Dr Neonin Mc Ardle
Directors loan | 3,464 | (2,077) | 1,450 | 2,838

Dividends paid to directors

Little 3 Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

|  | 2025 £ |  | 2024 £
Tomas Brendan O Neill |  |  |  |
Dividends |  | 1,000 |  | 1,000
Dr Neonin Mc Ardle |  |  |  |
Dividends |  | 1,000 |  | 1,000